These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7263341)

  • 1. Misonidazole and radiotherapy to treat malignant glioma: a phase II trial of the radiation therapy oncology group.
    Carabell SC; Bruno LA; Weinstein AS; Richter MP; Chang CH; Weiler CB; Goodman RL
    Int J Radiat Oncol Biol Phys; 1981 Jan; 7(1):71-7. PubMed ID: 7263341
    [No Abstract]   [Full Text] [Related]  

  • 2. Radiation therapy of rat brain tumor using misonidazole as hypoxic cell sensitizer.
    Tamura M; Inoue H; Murata M; Koizumi H; Nakamura M; Yonome I; Niibe H
    J Cancer Res Clin Oncol; 1985; 109(3):188-92. PubMed ID: 4008513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Split course multiple daily fractionated radiotherapy schedule combined with misonidazole for the management of grade III and IV gliomas. A pilot feasibility study of the Radiotherapy Group of the EORTC.
    Ang KK; van der Schueren E; Notter G; Horiot JC; Chenal C; Fauchon F; Raps J; van Peperzeel H; Goffin JC; Vessière M; van Glabbeke M
    Int J Radiat Oncol Biol Phys; 1982 Oct; 8(10):1657-64. PubMed ID: 6818185
    [No Abstract]   [Full Text] [Related]  

  • 4. Misonidazole in radiotherapy of supratentorial malignant brain gliomas in adult patients: a randomized double-blind study.
    Eur J Cancer Clin Oncol; 1983 Jan; 19(1):39-42. PubMed ID: 6343091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Misonidazole combined with hyperfractionation in the management of malignant glioma.
    Fulton DS; Urtasun RC; Shin KH; Geggie PH; Thomas H; Muller PJ; Moody J; Tanasichuk H; Mielke B; Johnson E
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1709-12. PubMed ID: 6090367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized study of misonidazole and radiotherapy for grade 3 and 4 cerebral astrocytoma.
    Bleehen NM; Wiltshire CR; Plowman PN; Watson JV; Gleave JR; Holmes AE; Lewin WS; Treip CS; Hawkins TD
    Br J Cancer; 1981 Apr; 43(4):436-42. PubMed ID: 7016157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: final report of an RTOG study.
    Nelson DF; Diener-West M; Weinstein AS; Schoenfeld D; Nelson JS; Sause WT; Chang CH; Goodman R; Carabell S
    Int J Radiat Oncol Biol Phys; 1986 Oct; 12(10):1793-800. PubMed ID: 3531110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical evaluation of radiosensitizing effects of misonidazole].
    Mitsuhashi N; Yonome I; Niibe H; Mogi K; Sakaino K; Nakajima N; Saito K; Suzuki Y; Sudo H; Okazaki A
    Nihon Igaku Hoshasen Gakkai Zasshi; 1984 Jul; 44(7):956-65. PubMed ID: 6514546
    [No Abstract]   [Full Text] [Related]  

  • 9. Multiple daily fractionated radiation therapy and misonidazole in the management of malignant astrocytoma. A preliminary report.
    Shin KH; Urtasun RC; Fulton D; Geggie PH; Tanasichuk H; Thomas H; Muller PJ; Curry B; Mielke B; Johnson E
    Cancer; 1985 Aug; 56(4):758-60. PubMed ID: 3893680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma.
    Deutsch M; Green SB; Strike TA; Burger PC; Robertson JT; Selker RG; Shapiro WR; Mealey J; Ransohoff J; Paoletti P
    Int J Radiat Oncol Biol Phys; 1989 Jun; 16(6):1389-96. PubMed ID: 2542193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trials of misonidazole in the United States.
    Wasserman TH; Stetz J; Phillips TL
    Cancer Clin Trials; 1981; 4(1):7-16. PubMed ID: 7214664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Postoperative radiotherapy of astrocytomas grade 3 and 4 with the radiosensitizer misonidazole. -End results of a multicentric controlled German study].
    Sack H; Calcanis A; Godehardt E; Weidtman V; Zülch KJ; Ammon J; Bamberg M; Herbst M; Keim H; Kleibel F; Makoski HB; Potthoff PC; Schlegel G; Schnepper E
    Strahlentherapie; 1982 Aug; 158(8):466-9. PubMed ID: 6753245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation Therapy Oncology Group clinical trials with misonidazole.
    Wasserman TH; Stetz J; Phillips TL
    Cancer; 1981 May; 47(10):2382-90. PubMed ID: 7023642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical experiences with the radiosensitizer Misonidazol (author's transl)].
    Bamberg M; Tamulevicius P; Streffer C; Scherer E
    Strahlentherapie; 1981 Aug; 157(8):524-36. PubMed ID: 7268822
    [No Abstract]   [Full Text] [Related]  

  • 15. Misonidazole as a radiosensitizer in the radiotherapy of glioblastomas and oesophageal cancer. Pharmacokinetic and clinical studies.
    Tamulevicius P; Bamberg M; Scherer E; Streffer C
    Br J Radiol; 1981 Apr; 54(640):318-24. PubMed ID: 7013890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misonidazole and unconventional radiation in advanced squamous cell carcinoma of the esophagus: a phase II study of the Radiation Therapy Oncology Group.
    Ydrach AA; Marcial VA; Parsons J; Concannon J; Asbell SO; George F
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):357-9. PubMed ID: 6809704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palliation of liver metastases with combined hepatic irradiation and misonidazole. Results of a Radiation Therapy Oncology Group Phase I-II study.
    Leibel SA; Order SE; Rominger CJ; Asbell SO
    Cancer Clin Trials; 1981; 4(3):285-93. PubMed ID: 6169464
    [No Abstract]   [Full Text] [Related]  

  • 18. Preliminary results of RTOG phase I/II study of misonidazole and radiation for bladder cancer.
    Mohiuddin M; Kramer S; Phillips T; Soberon M; Forgione H
    Am J Clin Oncol; 1982 Oct; 5(5):551-4. PubMed ID: 7180834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retreatment of pediatric brain tumors with radiation and misonidazole. Results of a CCSG/RTOG phase I/II study.
    Wara WM; Wallner KE; Levin VA; Liu HC; Edwards MS
    Cancer; 1986 Oct; 58(8):1636-40. PubMed ID: 3756787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery; preliminary results of an RTOG study.
    Nelson DF; Schoenfeld D; Weinstein AS; Nelson JS; Wasserman T; Goodman RL; Carabell S
    Int J Radiat Oncol Biol Phys; 1983 Aug; 9(8):1143-51. PubMed ID: 6347995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.